Concepedia

Hagop Kantarjian

HK

76

Publications

12.1K

Citations

43

H-Index

1983

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Fred Hutch Cancer Center

University of Chicago

University of Washington

Oregon Health & Science University

Hagop Kantarjian is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and oncology.

Top concepts

Publications per year

1983–2024

76

Publications

76

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus et al. · New England Journal of Medicine · 2002 · 2K citations · Full text

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Hagop Kantarjian, Anthony S. Stein, Nicola Gökbuget et al. · New England Journal of Medicine · 2017 · 2K citations · Full text

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus, Richard A. Larson, François Guilhot et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Hui Yang, Carlos E. Bueso‐Ramos, Courtney DiNardo et al. · Leukemia · 2013 · 670 citations · Full text

, , +5

Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

Hagop Kantarjian, Farhad Ravandi, Susan O’Brien et al. · Blood · 2010 · 391 citations · Full text

Rows per page

1–5 of 76